Doubling the Speed of Cell Line Development in a Large Pharmaceutical Company

For the past 10 years, the Cell Line Development (CLD) group at Janssen R&D (Spring House, PA) had used the same two-step process to develop the final cell cultures for manufacturing new biologic drugs. Thanks to Solentim VIPS™ technology by Advanced Instruments, they’ve reduced that process to single step – halving development times while still satisfying the clonality requirements of the Medicines’ Regulators.